Released: July 16, 2018

Defense Health Program
Department of Defense Psychological Health and Traumatic Brain Injury Research Program
Funding Opportunity for Fiscal Year 2018 (FY18)

The FY18 Defense Appropriation provides $125 million (M) to the Department of Defense Psychological Health and Traumatic Brain Injury Research Program (PHTBIRP) to support specific Defense Health Agency (DHA) J9 Directorate research program areas, including Joint Program Committee-5/Military Operational Medicine Research Program (JPC-5/MOMRP). As directed by the Office of the Assistant Secretary of Defense for Health Affairs, the DHA J9 Research and Development Directorate manages the Defense Health Program (DHP) Research, Development, Test, and Evaluation (RDT&E) appropriation. The managing agent for the anticipated Program Announcement/Funding Opportunity is the Congressionally Directed Medical Research Programs (CDMRP) at the U.S. Army Medical Research and Materiel Command (USAMRMC).

The PH/TBIRP and JPC-5/MOMRP are providing the information in this pre-announcement to allow investigators time to plan and develop applications. FY18 PHTBIRP Program Announcement and General Application Instructions for the following award mechanisms are anticipated to be posted on the website in August 2018. Pre-application and application deadlines will be available when the Program Announcement is released. This pre-announcement should not be construed as an obligation by the government.

Award Mechanism Eligibility Key Mechanism Elements Funding
Resiliency and Readiness Optimization/ Enhancement (R2OE)Translational Research Award Intramural (DoD) and extramural investigators at all academic levels (or equivalent) are eligible to submit applications.
  • Proposals/applications to the FY18 PHTBIRP R2OE Translational Research award should support research with the goal of evaluating evidence-based interventions and techniques to optimize and enhance resilience and psychological health readiness of Service members (SM). The expectation of this research is to demonstrate the utility of these resiliency and readiness enhancement interventions and techniques to benefit our SMs and the public at large.
  • The maximum period of performance is 3 years.
  • The maximum allowable total costs per award (direct and indirect) for the entire period of performance is $3M.

A pre-application is required and must be submitted through the electronic Biomedical Research Application Portal (eBRAP) at prior to the pre-application deadline. All applications must conform to the final Program Announcements and General Application Instructions that will be available for electronic downloading from the website. The application package containing the required forms for each award mechanism will also be found on A listing of all CDMRP and other USAMRMC extramural funding opportunities can be obtained on the website by performing a basic search using CFDA Number 12.420.

Submission deadlines are not available until the Program Announcements are released. For email notification when Program Announcements are released, subscribe to program-specific news and updates under “Email Subscriptions” on the eBRAP homepage at For more information about the PHTBIRP or other CDMRP-administered programs, please visit the CDMRP website (

Point of Contact:

CDMRP Public Affairs

Last updated Thursday, May 26, 2022